Loading...
Bilateral Trade Intelligence · $2.0M Total Trade · 104 Foreign Suppliers · 46 Indian Buyers · DGFT Verified · Updated March 2026
India imported $2.0M worth of pharmaceutical formulations from South Africa across 626 verified shipments, from 104 foreign suppliers to 46 Indian buyers. The top suppliers are FARMOVS (PTY) LTD ($1.5M) and ASPEN PHARMACARE ($64.3K). The leading products are Serum ($1.5M) and Plasma ($113K). Average shipment value: $3.2K.
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Serum | $1.5M | 73.4% |
| 2 | Plasma | $113.2K | 5.7% |
| 3 | Vitamin | $79.3K | 4.0% |
| 4 | Protein | $57.3K | 2.9% |
| 5 | Lactulose | $56.8K | 2.9% |
| 6 | Colchicine | $23.5K | 1.2% |
| 7 | Liraglutide | $22.3K | 1.1% |
| 8 | Tenofovir | $17.5K | 0.9% |
| 9 | Pemetrexed | $14.4K | 0.7% |
| 10 | Linezolid | $14.1K | 0.7% |
| 11 | Calcium | $10.3K | 0.5% |
| 12 | Artemether | $8.2K | 0.4% |
| 13 | Vaccine | $8.0K | 0.4% |
| 14 | Carfilzomib | $7.1K | 0.4% |
| 15 | Paclitaxel | $6.7K | 0.3% |
India imports 20+ pharmaceutical formulations from South Africa with a combined trade value of $2.0M. Key products include Serum ($1.5M), Plasma ($113K), Vitamin ($79K), Protein ($57K), Lactulose ($57K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 626 verified Indian Customs (DGFT) shipment records.
India exported pharmaceuticals worth $2.0M to South Africa across 626 verified shipments.
1. FARMOVS (PTY) LTD — $1.5M. 2. ASPEN PHARMACARE — $64.3K. 3. RELAX LIMITED — $56.8K. Total: 104 suppliers.
1. LAMBDA THERAPEUTIC RESEARCH LIMITED — $1.5M. 2. ALPHAMED FORMULATIONS PRIVATE LIMITED — $128.5K. 3. YASHRAJ BIOTECHNOLOGY LIMITED — $93.4K. 46 buyers total.
1. Serum ($1.5M, 73.4%); 2. Plasma ($113.2K, 5.7%); 3. Vitamin ($79.3K, 4.0%); 4. Protein ($57.3K, 2.9%); 5. Lactulose ($56.8K, 2.9%)
Export: . Import: .
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $2.0M corridor reflects quality compliance and pricing advantages.
These are the top pharmaceutical products exported from India to South Africa, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, South Africa buyers, regulatory requirements, and logistics for that specific product corridor. Products include Serum ($1.5M), Plasma ($113K), Vitamin ($79K), Protein ($57K), Lactulose ($57K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
104 Indian pharmaceutical companies export finished formulations to South Africa. Leading exporters include Farmovs (pty) Ltd, Aspen Pharmacare, Relax Limited, Biotech Africa. The top exporter accounts for 73.3% of total India–South Africa pharma exports. Source: Indian Customs (DGFT).
46 companies in South Africa import pharmaceutical formulations from India. Top buyers include Lambda Therapeutic Research Limited, Alphamed Formulations Private Limited, Yashraj Biotechnology Limited, Meril Diagnostics Private Limited. The largest buyer accounts for 73.6% of India–South Africa pharma imports. Source: Indian Customs (DGFT).
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
$3.2K per consignment across 626 shipments.
104 Indian companies. Largest: FARMOVS (PTY) LTD with $1.5M.
TransData Nexus covers 104 active exporters with shipment history and trade values at transdatanexus.com.
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 626 shipments.
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
104 Exporters
46 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists